Rubra Medicaments Financials

BSE: 531099

₹35.72

₹-1.87 (-4.97%)

As on 04-Sep-2026IST

Market cap

₹20 Cr

Revenue (TTM)

₹562 Cr

P/E Ratio

15.8

P/B Ratio

10.4

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	562.10	0.50	1.13	1.16	2.01	0.49
Total Income	562.10	0.50	1.13	1.16	2.01	0.49
Total Expenditure	560.08	0.44	1.10	1.24	2.03	0.48
EBITDA	2.02	0.06	0.03	-0.08	-0.02	0.01
Depreciation	0.01	0.01	0.01	0.00	0.00	0.00
EBIT	2.01	0.05	0.03	-0.08	-0.02	0.01
Interest	--	0.01	0.00	0.00	0.00	0.00
Other Income	--	0.00	0.00	0.00	0.00	0.00
Exceptional Items	--	--	--	--	--	--
Profit before Tax	2.01	0.05	0.02	-0.08	-0.02	0.01
Provision for Tax	0.77	0.02	-0.01	0.00	0.01	0.00
Profit after Tax	1.24	0.03	0.03	-0.08	-0.04	0.01

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	23.23	0.56	0.53	0.50	0.58	0.62
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	-0.01	0.00	0.00	0.00
Current Liabilities	319.67	0.09	0.40	0.16	0.27	0.29
Total Liabilities	342.90	0.65	0.93	0.66	0.85	0.90

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	0.02	--	0.07	0.06	0.01	0.01
Current Assets	342.89	0.65	0.86	0.60	0.83	0.89
Total Assets	342.90	0.65	0.93	0.66	0.85	0.90
Total Debt*	--	--	--	0.15	--	--
Net Current Assets	23.21	0.56	0.46	0.44	0.57	0.60
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	0.19	0.00	0.01	-0.50	0.52
Cash Flow from Investing Activities	--	-0.18	-0.01	--	--	--
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	--	0.01	-0.02	0.01	-0.50	0.52

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	2.26	0.05	0.06	-0.14	-0.07	0.01
Cash EPS (₹)	2.26	0.06	0.07	-0.14	-0.06	0.01
Adjusted Book Value (₹)	3.45	1.02	0.97	0.30	0.45	0.51
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.35	-0.01	0.03	-0.91	0.94
Free Cash Flow per Share (₹)	--	0.23	-0.02	0.03	-0.91	0.94

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	9.64	4.53	-13.10	-3.70	1.37
ROE (%)	9.81	4.66	8.66	-38.44	-13.95	2.02
ROA (%)	0.72	3.22	3.81	-10.43	-4.17	0.68
EBIT Margin (%)	0.36	10.28	2.29	-7.09	-1.14	1.73
Net Margin (%)	0.22	5.07	2.67	-6.76	-1.82	1.16
Cash Profit Margin (%)	0.00	6.64	3.29	-6.52	-1.74	1.49

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	4,540.45	-55.75	-2.60	-42.31	314.66	-50.89
EBIT Growth (%)	1,710.81	98.46	131.50	-257.43	-374.74	-48.37
Net Profit Growth (%)	1,322.32	-15.89	138.45	-115.10	-750.74	-82.22
EPS Growth (%)	1,288.45	-15.94	138.44	-114.97	-748.54	-82.15
Book Value Growth (%)	--	4.77	222.81	-32.25	-13.04	2.04

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	15.80	275.35	178.90	--	--	234.95
Price / Book Value	10.37	12.53	10.14	--	6.62	4.72
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	12.99	115.38	159.44	-71.89	-77.64	80.74
Close Price (₹)	38.60	12.79	9.88	--	2.95	2.42
High Price (₹)	144.40	19.44	12.39	--	4.26	2.79
Low Price (₹)	27.44	6.08	3.76	--	1.97	1.18
Market Cap (₹ Cr)	19.53	6.99	5.40	--	1.61	1.32

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	0.89	--	--
Short term debt to equity ratio	--	--	--	0.29	--	--
Current Ratio	1.07	6.92	2.14	3.83	3.15	3.11
Quick Ratio	1.07	6.92	2.14	3.83	3.15	3.11
Interest Coverage	--	10.12	6.09	-1,215.74	-195.28	31.26

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	60.08	57.00	62.59	37.09	33.13	45.46
Asset Turnover	3.27	0.63	1.43	1.54	2.30	0.59
Receivable days	--	362.19	183.72	172.49	80.47	192.10
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	90.65	0.62	2.63
Cash Conversion Cycle	--	--	--	81.84	79.85	189.46

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.